Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

CHRSCHRS
17 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in COHERUS ONCOLOGY INC

Yes. Goldman Sachs holds 602,075 shares of CHRS (Coherus Oncology), worth $842,905, as of its Q2 2026 13F filing. It reduced the position by 94,083 shares (-13.5%) from Q1 2026. Goldman Sachs has held CHRS in every 13F on record since Q2 2022, 17 quarterly filings.

Current Value

$842,905

Current Shares

602,075

Total Value Change

-$3.5M

Total Shares Change

+1,100

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
602,075
-13.5%
$842,9050.0%$1.40
0
2026-Q1
Increased
696,158
+126.7%
$1.2M0.0%$1.69
41
2025-Q4
Decreased
307,137
-19.8%
$436,1350.0%$1.42
0
2025-Q3
Increased
382,780
+15.6%
$627,7590.0%$1.64
28
2025-Q2
Decreased
331,117
-39.5%
$242,1460.0%$0.73
0
2025-Q1
Increased
547,707
+2.4%
$442,0000.0%$0.81
25
2024-Q4
Decreased
534,710
-74.3%
$737,9000.0%$1.38
0
2024-Q3
Decreased
2.1M
-3.8%
$2.2M0.0%$1.04
0
2024-Q2
Increased
2.2M
+26.0%
$3.7M0.0%$1.73
33
2024-Q1
Increased
1.7M
+104.7%
$4.1M0.0%$2.39
43
2023-Q4
Decreased
837,575
-36.6%
$2.8M0.0%$3.33
0
2023-Q3
Increased
1.3M
+152.0%
$4.9M0.0%$3.74
43
2023-Q2
Decreased
524,561
-22.5%
$2.2M0.0%$4.27
0
2023-Q1
Decreased
677,030
-3.5%
$4.6M0.0%$6.84
0
2022-Q4
Decreased
701,592
-9.2%
$5.6M0.0%$7.92
0
2022-Q3
Increased
772,222
+28.5%
$7.4M0.0%$9.61
34
2022-Q2
First report
600,975
-
$4.4M0.0%$7.24
0

Other major holders of CHRS: Temasek Holdings (Private) Ltd, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used